How durable is the effect of Mirabegron in successfully treated OAB patients? Secondary analysis of multicentre study

Svabik K1, Masata J1, Krhut J2, Zachoval R3, Hanus T4, Horcicka L5, Martan A1

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 10
Lower Urinary Tract and Therapeutics
Scientific Podium Short Oral Session 2
Wednesday 13th September 2017
09:22 - 09:30
Cavaniglia B
Overactive Bladder Pharmacology Urgency/Frequency
1. Ob/Gyn Dept, First Faculty of Medicine, Charles University, General University Hospital in Prague, 2. Dept. of Urology, University Hospital Ostrava, 3. Dept. of Urology, Thomayer Hospital Prague, 4. Dept. of Urology, First Faculty of Medicine, Charles University, General University Hospital in Prague, 5. GONA clinic Prague
Presenter
K

Kamil Svabik

Links

Abstract